# Oral Propranolol Improve Retinopathy of Prematurity Outcomes in Very Preterm Infants

> **NCT02977000** · NA · UNKNOWN · sponsor: **Huiqing Sun** · enrollment: 100 (estimated)

## Conditions studied

- Retinopathy of Prematurity

## Interventions

- **DRUG:** Propranolol

## Key facts

- **NCT ID:** NCT02977000
- **Lead sponsor:** Huiqing Sun
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2018-03
- **Final completion:** 2018-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2016-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02977000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02977000, "Oral Propranolol Improve Retinopathy of Prematurity Outcomes in Very Preterm Infants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02977000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*